Literature DB >> 10403908

Impaired expression of MHC class II molecules in response to interferon-gamma (IFN-gamma) on human thymoma neoplastic epithelial cells.

M Inoue1, M Okumura, S Miyoshi, H Shiono, K Fukuhara, Y Kadota, R Shirakura, H Matsuda.   

Abstract

A human thymoma is a neoplasm derived from the thymic epithelial cell, and is well known for its association with autoimmune diseases, especially myasthenia gravis. The neoplastic epithelial cells of thymoma clearly retain thymic epithelial functions, but the development of T cells in thymoma is somewhat impaired. In this study, we quantified by flow cytometry the in vitro expression of MHC molecules on neoplastic epithelial cells precultured with IFN-gamma. While MHC class I expression was comparable with that on normal thymic epithelial cells, the level of MHC class II molecules on neoplastic epithelial cells was lower than in controls, and also varied greatly from case to case. Additionally, there was a significant positive correlation between the expression level of MHC class II and the proportion of mature CD3+ cells in the CD4+CD8- subset. Thus, accumulation of CD3-CD4+CD8- cells in thymoma may result from impaired expression of the MHC class II molecules, suggesting that the function of the neoplastic epithelial cells might determine the maturation and the positively selected repertoire of T cells in thymomas.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10403908      PMCID: PMC1905478          DOI: 10.1046/j.1365-2249.1999.00933.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  37 in total

1.  Thymoma: a clinicopathologic study.

Authors:  P E BERNATZ; E G HARRISON; O T CLAGETT
Journal:  J Thorac Cardiovasc Surg       Date:  1961-10       Impact factor: 5.209

2.  Pathogenesis of myasthenia gravis. Acetylcholine receptor-related antigenic determinants in tumor-free thymuses and thymic epithelial tumors.

Authors:  T Kirchner; S Tzartos; F Hoppe; B Schalke; H Wekerle; H K Müller-Hermelink
Journal:  Am J Pathol       Date:  1988-02       Impact factor: 4.307

3.  Thymoma: a clinical and pathological study of 65 cases.

Authors:  W R Salyer; J C Eggleston
Journal:  Cancer       Date:  1976-01       Impact factor: 6.860

4.  Subpopulations of lymphocytes in human thymomas.

Authors:  L Lauriola; M Piantelli; A Carbone; M A Dina; C Scoppetta; P Musiani
Journal:  Clin Exp Immunol       Date:  1979-09       Impact factor: 4.330

5.  Thymoma epithelial cells secrete thymic hormone but do not express class II antigens of the major histocompatibility complex.

Authors:  W Savino; G Manganella; J M Verley; A Wolff; S Berrih; P Levasseur; J P Binet; M Dardenne; J F Bach
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

6.  An immunohistologic study of the epithelial and lymphoid components of six thymomas.

Authors:  T H van der Kwast; E van Vliet; E Cristen; W van Ewijk; R O van der Heul
Journal:  Hum Pathol       Date:  1985-10       Impact factor: 3.466

7.  Myasthenia gravis: immunohistological heterogeneity in microenvironmental organization of hyperplastic and neoplastic thymuses suggesting different mechanisms of tolerance breakdown.

Authors:  M Chilosi; A Iannucci; L Fiore-Donati; G Tridente; M Pampanin; G Pizzolo; M Ritter; M Bofill; G Janossy
Journal:  J Neuroimmunol       Date:  1986-05       Impact factor: 3.478

8.  Follow-up study of thymomas with special reference to their clinical stages.

Authors:  A Masaoka; Y Monden; K Nakahara; T Tanioka
Journal:  Cancer       Date:  1981-12-01       Impact factor: 6.860

9.  Human thymoma: immunologic characteristics of the lymphocytic component.

Authors:  L Lauriola; N Maggiano; M Marino; A Carbone; M Piantelli; P Musiani
Journal:  Cancer       Date:  1981-11-01       Impact factor: 6.860

10.  Myasthenic and nonmyasthenic thymoma. An expansion of a minor cortical epithelial cell subset?

Authors:  N Willcox; M Schluep; M A Ritter; H J Schuurman; J Newsom-Davis; B Christensson
Journal:  Am J Pathol       Date:  1987-06       Impact factor: 4.307

View more
  5 in total

1.  Altered T cell development in human thymoma is related to impairment of MHC class II transactivator expression induced by interferon-gamma (IFN-gamma).

Authors:  Y Kadota; M Okumura; S Miyoshi; S Kitagawa-Sakakida; M Inoue; H Shiono; Y Maeda; T Kinoshita; R Shirakura; H Matsuda
Journal:  Clin Exp Immunol       Date:  2000-07       Impact factor: 4.330

2.  Glucocorticoids induce G1 cell cycle arrest in human neoplastic thymic epithelial cells.

Authors:  Yasunobu Funakoshi; Hiroyuki Shiono; Masayoshi Inoue; Yoshihisa Kadota; Mitsunori Ohta; Hikaru Matsuda; Meinoshin Okumura; Tadaaki Eimoto
Journal:  J Cancer Res Clin Oncol       Date:  2005-02-10       Impact factor: 4.553

3.  Characterization of T cell maturity in thymic epithelial cell tumors from BUF/Mna spontaneous thymoma rats and BUF/Mna-Rnu/+ rats showing delayed thymomagenesis.

Authors:  Masayoshi Inoue; Mutsushi Matsuyama; Hiroyuki Shiono; Osamu Honda; Hiromitsu Sumikawa; Noriyuki Tomiyama; Meinoshin Okumura
Journal:  Int J Clin Exp Pathol       Date:  2010-06-30

Review 4.  Immunological function of thymoma and pathogenesis of paraneoplastic myasthenia gravis.

Authors:  Meinoshin Okumura; Yoshitaka Fujii; Hiroyuki Shiono; Masayoshi Inoue; Masato Minami; Tomoki Utsumi; Yoshihisa Kadota; Yoshiki Sawa
Journal:  Gen Thorac Cardiovasc Surg       Date:  2008-04-10

5.  Chromosome 6 suffers frequent and multiple aberrations in thymoma.

Authors:  Masayoshi Inoue; Alexander Marx; Andreas Zettl; Philipp Ströbel; Hans-Konrad Müller-Hermelink; Petr Starostik
Journal:  Am J Pathol       Date:  2002-10       Impact factor: 4.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.